Literature DB >> 4055916

Induction and/or selective retention of proteins in mammalian cells exposed to cycloheximide.

V Sorrentino, A Battistini, A M Curatola, P Di Francesco, G B Rossi.   

Abstract

Exposure of a number of murine and human cell lines to low graded doses of cycloheximide (CXM) results in a pattern of protein synthesis consisting of enhanced and induced species. These can be divided into two main classes according to molecular weight (20-40 and 70-120 Kd), similar to what has been described for other agents that modify the physiological conditions of growth. In addition, the pronounced synthesis of a hitherto unreported 50-Kd protein species has been consistently observed in all lines tested. Simultaneous exposure of cells to CXM and actinomycin D results in suppressing synthesis of some but not all protein species observed, indicating that control mechanisms at both transcriptional and posttranscriptional levels may be operative in this system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055916     DOI: 10.1002/jcp.1041250221

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts.

Authors:  H A Young; L Varesio; P Hwu
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

2.  Serum and insulin inhibit cell death induced by cycloheximide in the human breast cancer cell line MCF-7.

Authors:  A Geier; R Beery; M Haimshon; R Hemi; B Lunenfeld
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

3.  Epidermal growth factor and insulin-like growth factor-1 preserve cell viability in the absence of protein synthesis.

Authors:  A Geier; R Hemi; M Haimson; R Beery
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

4.  Insulinlike growth factor-1 inhibits cell death induced by cycloheximide in MCF-7 cells: a model system for analyzing control of cell death.

Authors:  A Geier; M Haimshon; R Beery; R Hemi; B Lunenfeld
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.